2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Mortality
Cancer mortality persists as a pivotal focus in the realm of cancer research, driving relentless exploration and innovation. Breakthrough treatment methodologies, such as targeted therapies and immunotherapies, hold promise in curbing mortality rates. Advancements in early detection techniques, such as sophisticated imaging technologies and liquid biopsies, are revolutionizing diagnostic accuracy and facilitating timely interventions. Furthermore, an in-depth comprehension of cancer's molecular intricacies is catalyzing the development of personalized treatment regimens, tailored to individual genetic profiles. Effective collaboration among researchers, healthcare practitioners, and policymakers is imperative in translating these advancements into tangible outcomes, ultimately alleviating the global burden of cancer mortality. Despite the challenges ahead, the trajectory of cancer research continues to chart a course towards improved survival rates and elevated quality of life for those impacted by this pervasive disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China